AI ‘Fragle’ Method Makes Cancer Tracking More Efficient
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read MorePosted by Chris Wolski | Jun 18, 2025 | Cancer |
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read MorePosted by Chris Wolski | Jun 11, 2025 | Cancer |
Florida Cancer Specialists & Research Institute now offers liquid biopsy, a minimally invasive blood test that enhances cancer diagnosis.
Read MorePosted by Chris Wolski | May 13, 2025 | Cancer |
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.
Read MorePosted by Chris Wolski | May 7, 2025 | Cancer |
New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.
Read MorePosted by Chris Wolski | Apr 22, 2025 | Cancer |
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
Read More